{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:34:27Z","timestamp":1789043667005,"version":"build-2803163510"},"reference-count":49,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>This phase 1\/2 study assessed the augmentation of reduced-intensity conditioning (RIC) with total marrow and lymph node irradiation (TMLI), for peripheral blood stem cell transplantation, in patients with advanced hematologic disease. The regimen consisted of fludarabine 25 mg\/m2 per day for 5 days, melphalan 140 mg\/m2 for one day, and TMLI radiation at 150 cGy\/fraction in 8 fractions over 4 days. Eligible patients were over 50 years old and\/or had compromised organ function. Median age of the 33 evaluable patients was 55.2 years. Eighteen events of nonhematologic grade III or higher toxicities occurred in 9 patients. Day 30 and day 100 mortalities were 3% and 15%, respectively. Patients achieved myeloid and platelet engraftment at a median of 14 days after transplantation. Long-term toxicities occurred in 2 patients: hypokalemia and tremor, both grade III, on days 370 and 361 after transplantation. Fourteen patients died, 7 of relapse-related causes and 7 of non\u2013relapse-related causes. With a median follow-up for living patients of 14.7 months, 1-year overall survival, event-free survival, and non\u2013relapse-related mortality were 75%, 65%, and 19%, respectively. Addition of TMLI to RIC is feasible and safe and could be offered to patients with advanced hematologic malignancies who might not otherwise be candidates for RIC.<\/jats:p>","DOI":"10.1182\/blood-2010-06-288357","type":"journal-article","created":{"date-parts":[[2010,9,29]],"date-time":"2010-09-29T03:52:19Z","timestamp":1285732339000},"page":"309-315","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":85,"title":["Phase 1\/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies"],"prefix":"10.1182","volume":"117","author":[{"given":"Joseph","family":"Rosenthal","sequence":"first","affiliation":[{"name":"Departments of Hematology\/Hematopoietic Stem Cell Transplantation,"},{"name":"Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Wong","sequence":"additional","affiliation":[{"name":"Radiation Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Stein","sequence":"additional","affiliation":[{"name":"Departments of Hematology\/Hematopoietic Stem Cell Transplantation,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajun","family":"Qian","sequence":"additional","affiliation":[{"name":"Information Sciences, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Hitt","sequence":"additional","affiliation":[{"name":"Departments of Hematology\/Hematopoietic Stem Cell Transplantation,"},{"name":"Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossameldin","family":"Naeem","sequence":"additional","affiliation":[{"name":"Departments of Hematology\/Hematopoietic Stem Cell Transplantation,"},{"name":"Pediatrics,"},{"name":"Information Sciences, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Dagis","sequence":"additional","affiliation":[{"name":"Information Sciences, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra H.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Departments of Hematology\/Hematopoietic Stem Cell Transplantation,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Forman","sequence":"additional","affiliation":[{"name":"Departments of Hematology\/Hematopoietic Stem Cell Transplantation,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"11","key":"2019111807201814300_B1","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1182\/blood.V97.11.3669","article-title":"Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission.","volume":"97","author":"Blaise","year":"2001","journal-title":"Blood"},{"issue":"9","key":"2019111807201814300_B2","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V83.9.2723.2723","article-title":"A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group.","volume":"83","author":"Ringden","year":"1994","journal-title":"Blood"},{"issue":"6","key":"2019111807201814300_B3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.bmt.1704198","article-title":"Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study.","volume":"32","author":"Bunin","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111807201814300_B4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1200\/JCO.2000.18.2.340","article-title":"Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia.","volume":"18","author":"Davies","year":"2000","journal-title":"J Clin Oncol"},{"issue":"9","key":"2019111807201814300_B5","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/blood.V76.9.1867.1867","article-title":"Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.","volume":"76","author":"Clift","year":"1990","journal-title":"Blood"},{"issue":"8","key":"2019111807201814300_B6","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1182\/blood.V77.8.1660.1660","article-title":"Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens.","volume":"77","author":"Clift","year":"1991","journal-title":"Blood"},{"issue":"4","key":"2019111807201814300_B7","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1182\/blood.V92.4.1455","article-title":"Long-term follow-up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia.","volume":"92","author":"Clift","year":"1998","journal-title":"Blood"},{"issue":"2","key":"2019111807201814300_B8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0167-8140(91)90008-5","article-title":"Lung damage following bone marrow transplantation after hyperfractionated total body irradiation.","volume":"22","author":"Latini","year":"1991","journal-title":"Radiother Oncol"},{"issue":"1","key":"2019111807201814300_B9","first-page":"71","article-title":"Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation.","volume":"15","author":"Boulad","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2019111807201814300_B10","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1200\/JCO.1997.15.6.2238","article-title":"Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation\u2014a report from the Societe Francaise de Greffe de Moelle.","volume":"15","author":"Michel","year":"1997","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111807201814300_B11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0360-3016(97)00578-6","article-title":"High-energy total body irradiation as preparation for bone marrow transplantation in leukemia patients: treatment technique and related complications.","volume":"40","author":"Bradley","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"2019111807201814300_B12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.bmt.1704945","article-title":"Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia.","volume":"35","author":"Berger","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"13","key":"2019111807201814300_B13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199703273361301","article-title":"Solid cancers after bone marrow transplantation.","volume":"336","author":"Curtis","year":"1997","journal-title":"N Engl J Med"},{"issue":"10","key":"2019111807201814300_B14","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1200\/JCO.1994.12.10.2187","article-title":"Secondary malignancies after bone marrow transplantation in adults.","volume":"12","author":"Lowsky","year":"1994","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111807201814300_B15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1200\/JCO.2000.18.2.348","article-title":"New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia.","volume":"18","author":"Socie","year":"2000","journal-title":"J Clin Oncol"},{"issue":"3","key":"2019111807201814300_B16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1182\/blood.V97.3.631","article-title":"Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.","volume":"97","author":"Giralt","year":"2001","journal-title":"Blood"},{"issue":"8","key":"2019111807201814300_B17","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1182\/blood-2003-03-0855","article-title":"Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years.","volume":"102","author":"Wong","year":"2003","journal-title":"Blood"},{"issue":"10","key":"2019111807201814300_B18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1083-8791(03)00241-6","article-title":"Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed.","volume":"9","author":"Fung","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2019111807201814300_B19","first-page":"621","article-title":"Reinventing bone marrow transplantation: nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect.","volume":"13","author":"Champlin","year":"1999","journal-title":"Oncology (Williston Park)"},{"issue":"7","key":"2019111807201814300_B20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.bbmt.2007.03.011","article-title":"Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program.","volume":"13","author":"Giralt","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2019111807201814300_B21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.bmt.1705278","article-title":"Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies.","volume":"37","author":"Petropoulos","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2019111807201814300_B22","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1118\/1.1576395","article-title":"Benchmarking beam alignment for a clinical helical tomotherapy device.","volume":"30","author":"Balog","year":"2003","journal-title":"Med Phys"},{"issue":"3","key":"2019111807201814300_B23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbmt.2005.10.026","article-title":"Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total body irradiation.","volume":"12","author":"Wong","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2019111807201814300_B24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijrobp.2008.04.071","article-title":"Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation.","volume":"73","author":"Wong","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2019111807201814300_B25","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.ijrobp.2006.10.047","article-title":"Image-guided total marrow and total lymphatic irradiation using helical tomotherapy.","volume":"67","author":"Schultheiss","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2019111807201814300_B26","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk.","volume":"16","author":"Robert","year":"1988","journal-title":"Ann Statist"},{"issue":"10","key":"2019111807201814300_B27","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation.","volume":"6","author":"Bearman","year":"1988","journal-title":"J Clin Oncol"},{"issue":"11","key":"2019111807201814300_B28","first-page":"1687","article-title":"HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission.","volume":"10","author":"Gale","year":"1996","journal-title":"Leukemia"},{"issue":"5","key":"2019111807201814300_B29","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.1997.15.5.1767","article-title":"Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.","volume":"15","author":"Szydlo","year":"1997","journal-title":"J Clin Oncol"},{"issue":"19","key":"2019111807201814300_B30","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM199411103311902","article-title":"Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.","volume":"331","author":"Barrett","year":"1994","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111807201814300_B31","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1182\/blood.V80.4.1090.1090","article-title":"Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy.","volume":"80","author":"Biggs","year":"1992","journal-title":"Blood"},{"issue":"4","key":"2019111807201814300_B32","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1182\/blood.V71.4.888.888","article-title":"High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission.","volume":"71","author":"Coccia","year":"1988","journal-title":"Blood"},{"issue":"1","key":"2019111807201814300_B33","first-page":"9","article-title":"Bone marrow transplantation for acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: lack of superiority over cyclophosphamide-containing conditioning regimens.","volume":"6","author":"Woods","year":"1990","journal-title":"Bone Marrow Transplant"},{"issue":"26","key":"2019111807201814300_B34","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM198712243172602","article-title":"Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia.","volume":"317","author":"Brochstein","year":"1987","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111807201814300_B35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1200\/JCO.1999.17.1.197","article-title":"Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study.","volume":"17","author":"Boulad","year":"1999","journal-title":"J Clin Oncol"},{"issue":"3","key":"2019111807201814300_B36","first-page":"118","article-title":"Interstitial pneumonitis after allogeneic bone marrow transplantation following total body irradiation.","volume":"9","author":"Kurisu","year":"1991","journal-title":"Radiat Med"},{"issue":"5","key":"2019111807201814300_B37","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3324\/haematol.10924","article-title":"Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC).","volume":"92","author":"Vigouroux","year":"2007","journal-title":"Haematologica"},{"issue":"4","key":"2019111807201814300_B38","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3324\/haematol.10867","article-title":"Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia.","volume":"92","author":"Blaise","year":"2007","journal-title":"Haematologica"},{"issue":"9","key":"2019111807201814300_B39","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1182\/blood-2007-04-085969","article-title":"Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia.","volume":"110","author":"Kebriaei","year":"2007","journal-title":"Blood"},{"issue":"6","key":"2019111807201814300_B40","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.bmt.1703198","article-title":"Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant.","volume":"28","author":"Devine","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"2019111807201814300_B41","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.bbmt.2009.07.003","article-title":"Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia.","volume":"15","author":"Stein","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2019111807201814300_B42","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1182\/blood.V99.3.731","article-title":"Comparison of 200 mg\/m2 melphalan and 8 Gy total body irradiation plus 140 mg\/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial.","volume":"99","author":"Moreau","year":"2002","journal-title":"Blood"},{"issue":"1","key":"2019111807201814300_B43","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1053-4296(99)80058-7","article-title":"Tomotherapy.","volume":"9","author":"Mackie","year":"1999","journal-title":"Semin Radiat Oncol"},{"issue":"3","key":"2019111807201814300_B44","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood-2003-11-3750","article-title":"Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation.","volume":"104","author":"de Lima","year":"2004","journal-title":"Blood"},{"issue":"7","key":"2019111807201814300_B45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1083-8791(03)00128-9","article-title":"Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalan.","volume":"9","author":"Ritchie","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2019111807201814300_B46","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood.V99.3.1071","article-title":"Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen.","volume":"99","author":"Chakraverty","year":"2002","journal-title":"Blood"},{"issue":"5","key":"2019111807201814300_B47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.bmt.1704166","article-title":"Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies.","volume":"32","author":"van Besien","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2019111807201814300_B48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.bmt.1703652","article-title":"Fludarabine\/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma.","volume":"30","author":"Giralt","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2019111807201814300_B49","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1365-2141.2001.03153.x","article-title":"Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study.","volume":"115","author":"Martino","year":"2001","journal-title":"Br J Haematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/117\/1\/309\/1336914\/zh800111000309.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/117\/1\/309\/1336914\/zh800111000309.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T12:27:14Z","timestamp":1574080034000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/117\/1\/309\/28808\/Phase-12-trial-of-total-marrow-and-lymph-node"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,6]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1,6]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2010-06-288357","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,6]]}}}